Sphingosine Kinase 2 in Autoimmune/Inflammatory Disease and the Development of Sphingosine Kinase 2 Inhibitors.


:The purpose of this Opinion is to present a case for targeting sphingosine kinase 2 (SK2) in autoimmune/inflammatory disease. Data obtained using Sphk2-/- mice suggest that SK2 is an anti-inflammatory enzyme, although this might be misleading because of a compensatory increase in the expression of a second isoform, sphingosine kinase 1 (SK1), which functions as a proinflammatory enzyme. SK2 is involved in regulating interleukin (IL)-12/interferon gamma (IFN-γ) and histone deacetylase-1/2 (HDAC-1/2) signalling and, potentially, retinoid-related orphan receptor gamma t (ROR-γt) stability linked with T helper (Th) 17 cell polarisation. Therefore, there is a need to develop highly potent SK2 inhibitors with selectivity over SK1 to clearly define the role of SK2 in autoimmune/inflammatory disease. Structural determinants of SK2 relative to SK1 will enable the design of selective SK2 inhibitors.


Trends Pharmacol Sci


Pyne NJ,Adams DR,Pyne S




Has Abstract


2017-07-01 00:00:00














  • Newly discovered tachykinins raise new questions about their peripheral roles and the tachykinin nomenclature.

    abstract::The tachykinin family has recently been extended by the discovery of a third tachykinin gene encoding previously unknown mammalian tachykinins (hemokinin 1, endokinin A and endokinin B) that have a widespread peripheral distribution and a tachykinin NK(1) receptor selectivity. This and the identification of other tach...

    journal_title:Trends in pharmacological sciences

    pub_type: 杂志文章,评审


    authors: Patacchini R,Lecci A,Holzer P,Maggi CA

    更新日期:2004-01-01 00:00:00

  • Subcellular Organization of GPCR Signaling.

    abstract::G protein-coupled receptors (GPCRs) comprise a large and diverse class of signal-transducing receptors that undergo dynamic and isoform-specific membrane trafficking. GPCRs thus have an inherent potential to initiate or regulate signaling reactions from multiple membrane locations. This review discusses emerging insig...

    journal_title:Trends in pharmacological sciences

    pub_type: 杂志文章,评审


    authors: Eichel K,von Zastrow M

    更新日期:2018-02-01 00:00:00

  • Blocking interactions between HIV-1 integrase and cellular cofactors: an emerging anti-retroviral strategy.

    abstract::HIV-1 integrase (IN) executes the insertion of proviral DNA into the host cell genome, an essential step in the retroviral life cycle. This is a multi-step process that starts in the cytosol and culminates in the nucleus of the infected cell. It is becoming increasingly clear that IN interacts with a wide range of dif...

    journal_title:Trends in pharmacological sciences

    pub_type: 杂志文章,评审


    authors: Al-Mawsawi LQ,Neamati N

    更新日期:2007-10-01 00:00:00

  • Anti-inflammatory actions of steroids: molecular mechanisms.

    abstract::Glucocorticosteroids are highly effective in controlling inflammation and the molecular mechanisms involved are now becoming clear. Activation of glucocorticoid receptors results in increased or decreased transcription of a number of genes involved in the inflammatory process. Of particular importance is the repressio...

    journal_title:Trends in pharmacological sciences

    pub_type: 杂志文章,评审


    authors: Barnes PJ,Adcock I

    更新日期:1993-12-01 00:00:00

  • 5-HT2 receptor subtypes: a family re-united?

    abstract::The current classification for 5-HT2 receptors accommodates three subtypes. In addition to the originally defined 5-HT2 receptor, sanctuary is now provided for the structurally related 5-HT1c receptor (now 5-HT2c) and at least one atypical 5-HT receptor subtype. The strong functional union of this family is reflected ...

    journal_title:Trends in pharmacological sciences

    pub_type: 杂志文章,评审


    authors: Baxter G,Kennett G,Blaney F,Blackburn T

    更新日期:1995-03-01 00:00:00

  • Non-genomic loss of PTEN function in cancer: not in my genes.

    abstract::Loss of function of the phosphatase and tensin homolog (PTEN) tumour suppressor contributes to the development of many cancers. However, in contrast to classical models of tumour suppression, partial loss of PTEN function appears to be frequently observed in the clinic. In addition, studies of both humans and mice wit...

    journal_title:Trends in pharmacological sciences

    pub_type: 杂志文章,评审


    authors: Leslie NR,Foti M

    更新日期:2011-03-01 00:00:00

  • Do computer simulations of laboratory practicals meet learning needs?

    abstract::There is a variety of pressures on pharmacology teachers to replace real laboratory practicals with simulations but do they help students achieve the required learning objectives? In this article, the marks obtained by students in a variety of assessments using 'wet' or simulated practicals are analysed. Poorer perfor...

    journal_title:Trends in pharmacological sciences

    pub_type: 杂志文章,评审


    authors: Hughes IE

    更新日期:2001-02-01 00:00:00

  • Heterogeneity of the endothelial cell and its role in organ preference of tumour metastasis.

    abstract::The vascular endothelium is a remarkably heterogeneous organ. In addition to well-characterized anatomical diversity in situ, specific differences are increasingly being recognized between surface antigens on endothelial cells from different tissues, including absence of the classic endothelial marker factor VIII-rela...

    journal_title:Trends in pharmacological sciences

    pub_type: 杂志文章,评审


    authors: McCarthy SA,Kuzu I,Gatter KC,Bicknell R

    更新日期:1991-12-01 00:00:00

  • Preclinical models of antipsychotic drug-induced metabolic side effects.

    abstract::Antipsychotic drugs (APDs), and the 'atypical' APDs in particular, are commonly associated with metabolic side effects in humans. These include glucose dysregulation, insulin resistance, hyperlipidemia, weight gain and hypertension, which put patients at increased risk of cardiometabolic disorders. The underlying biol...

    journal_title:Trends in pharmacological sciences

    pub_type: 杂志文章,评审


    authors: Boyda HN,Tse L,Procyshyn RM,Honer WG,Barr AM

    更新日期:2010-10-01 00:00:00

  • 5-HT3 receptors in the CNS: 3B or not 3B?

    abstract::5-HT(3) receptors are widely distributed in the CNS and PNS where they participate in a variety of physiological processes. Native 5-HT(3) receptors in the CNS display functional and pharmacological heterogeneity, suggesting the existence of multiple receptor subunits. However, recent evidence suggests that of the two...

    journal_title:Trends in pharmacological sciences

    pub_type: 杂志文章,评审


    authors: van Hooft JA,Yakel JL

    更新日期:2003-04-01 00:00:00

  • Historical review: a brief history and personal retrospective of seven-transmembrane receptors.

    abstract::Pharmacologists have studied receptors for more than a century but a molecular understanding of their properties has emerged only during the past 30-35 years. In this article, I provide a personal retrospective of how developments and discoveries primarily during the 1970s and 1980s led to current concepts about the l...

    journal_title:Trends in pharmacological sciences

    pub_type: 历史文章,杂志文章


    authors: Lefkowitz RJ

    更新日期:2004-08-01 00:00:00

  • The darker side of Ca2+ signaling by neuronal Ca2+-sensor proteins: from Alzheimer's disease to cancer.

    abstract::Neuronal Ca2+-sensor (NCS) proteins constitute a subfamily of closely related EF-hand Ca2+-binding proteins that are expressed mainly in neurons or retinal photoreceptor cells. A variety of different neuronal functions have been attributed to these proteins. However, important new discoveries indicate that these prote...

    journal_title:Trends in pharmacological sciences

    pub_type: 杂志文章,评审


    authors: Braunewell KH

    更新日期:2005-07-01 00:00:00

  • 007 (x2)-3-3: 14-3-3 Targeted Compounds as Double Agents.

    abstract::14-3-3 Proteins enact a range of cellular functions through protein-protein interactions (PPIs) with client proteins. Kaplan and colleagues recently demonstrated that a semisynthetic compound was able to selectively stabilize or disrupt specific interactions, depending on the binding partner. This finding presents an ...

    journal_title:Trends in pharmacological sciences

    pub_type: 评论,杂志文章


    authors: Gannon M,Yacoubian TA

    更新日期:2020-07-01 00:00:00

  • The annexin 1 receptor(s): is the plot unravelling?

    abstract::Recent studies have proposed a functional link between annexin 1 (ANXA1), an endogenous anti-inflammatory mediator, and receptors of the formyl-peptide family. In particular, exogenous and endogenous ANXA1 and its peptidomimetics interact with one member of this family, the formyl-peptide-receptor-like 1. Further anal...

    journal_title:Trends in pharmacological sciences

    pub_type: 杂志文章,评审


    authors: Perretti M

    更新日期:2003-11-01 00:00:00

  • The minor binding pocket: a major player in 7TM receptor activation.

    abstract::From the deep part of the main ligand-binding crevice, a minor, often shallower pocket extends between the extracellular ends of transmembrane domains (TM)-I, II, III and VII of 7TM receptors. This minor binding pocket is defined by a highly conserved kink in TM-II that is induced by a proline residue located in one o...

    journal_title:Trends in pharmacological sciences

    pub_type: 杂志文章


    authors: Rosenkilde MM,Benned-Jensen T,Frimurer TM,Schwartz TW

    更新日期:2010-12-01 00:00:00

  • Collateral efficacy in drug discovery: taking advantage of the good (allosteric) nature of 7TM receptors.

    abstract::Seven-transmembrane receptors are prototypic allosteric proteins with the ability to adopt numerous conformations, many of which interact with cellular partners to initiate cellular biochemical processes. Defining efficacy as the ability of ligands to stabilize some of these conformations (which, in turn, possess phys...

    journal_title:Trends in pharmacological sciences

    pub_type: 杂志文章,评审


    authors: Kenakin T

    更新日期:2007-08-01 00:00:00

  • Novel interactions between K+ channels and scorpion toxins.

    abstract::K(+) channels are macromolecules embedded in biological membranes, where they play a key role in cellular excitability and signal transduction pathways. Knowledge of their structure should help improve our understanding of their function and lead to the design of therapeutic compounds. Most pharmacological and structu...

    journal_title:Trends in pharmacological sciences

    pub_type: 杂志文章,评审


    authors: Rodríguez de la Vega RC,Merino E,Becerril B,Possani LD

    更新日期:2003-05-01 00:00:00

  • Use of transgenic mice to study voltage-dependent Ca2+ channels.

    abstract::During the past decade a great number of genes encoding high- and low-voltage-dependent Ca(2+) channels and their accessory subunits have been cloned. Studies of Ca(2+) channel structure-function relationships and channel regulation using cDNA expression in heterologous expression systems have revealed intricate detai...

    journal_title:Trends in pharmacological sciences

    pub_type: 杂志文章,评审


    authors: Muth JN,Varadi G,Schwartz A

    更新日期:2001-10-01 00:00:00

  • Feedback Activation of STAT3 as a Cancer Drug-Resistance Mechanism.

    abstract::Signal transducer and activator of transcription 3 (STAT3) plays crucial roles in several cellular processes such as cell proliferation and survival, and has been found to be aberrantly activated in many cancers. Much research has explored the leading mechanisms for regulating the STAT3 pathway and its role in promoti...

    journal_title:Trends in pharmacological sciences

    pub_type: 杂志文章,评审


    authors: Zhao C,Li H,Lin HJ,Yang S,Lin J,Liang G

    更新日期:2016-01-01 00:00:00

  • Neurobiology and treatment of Parkinson's disease.

    abstract::Parkinson's disease (PD) is the second most common neurodegenerative disorder after Alzheimer's disease and is an important cause of chronic disability. Numerous important advances have been made in our understanding of the aetiopathogenesis, pathology and clinical phenomenology of this disease, and these have underpi...

    journal_title:Trends in pharmacological sciences

    pub_type: 杂志文章,评审


    authors: Schapira AH

    更新日期:2009-01-01 00:00:00

  • Machine Learning for Biologics: Opportunities for Protein Engineering, Developability, and Formulation.

    abstract::Successful biologics must satisfy multiple properties including activity and particular physicochemical features that are globally defined as developability. These multiple properties must be simultaneously optimized in a very broad design space of protein sequences and buffer compositions. In this context, artificial...

    journal_title:Trends in pharmacological sciences

    pub_type: 杂志文章,评审


    authors: Narayanan H,Dingfelder F,Butté A,Lorenzen N,Sokolov M,Arosio P

    更新日期:2021-01-23 00:00:00

  • An escort for GPCRs: implications for regulation of receptor density at the cell surface.

    abstract::G-protein-coupled receptors (GPCRs) are dynamically regulated by various mechanisms that tune their response to external stimuli. Modulation of their plasma membrane density, via trafficking between subcellular compartments, constitutes an important process in this context. Substantial information has been accumulated...

    journal_title:Trends in pharmacological sciences

    pub_type: 杂志文章,评审


    authors: Achour L,Labbé-Jullié C,Scott MG,Marullo S

    更新日期:2008-10-01 00:00:00

  • Agonist regulation of cellular G protein levels and distribution: mechanisms and functional implications.

    abstract::Exposure of cells to agonists of receptors linked to G proteins can result in downregulation of cellular levels or redistribution of G proteins from membranes to the cytosol. Agonist-induced reductions in G protein levels have been observed for members of each of the Gs, Gi and Gq families of G proteins, are likely to...

    journal_title:Trends in pharmacological sciences

    pub_type: 杂志文章,评审


    authors: Milligan G

    更新日期:1993-11-01 00:00:00

  • Turning on cGMP-dependent pathways to treat cardiac dysfunctions: boom, bust, and beyond.

    abstract::cGMP inhibits hypertrophy, decreases fibrosis, and protects against cardiac ischemia-reperfusion (I/R) injury. Gene-targeting studies have not defined a clear role for its major downstream effector, cGMP-dependent protein kinase I (cGKI), in cardiac hypertrophy, but do implicate cGMP-cGKI signaling in fibrosis and I/R...

    journal_title:Trends in pharmacological sciences

    pub_type: 杂志文章,评审


    authors: Lukowski R,Krieg T,Rybalkin SD,Beavo J,Hofmann F

    更新日期:2014-08-01 00:00:00

  • Techniques: reporter mice - a new way to look at drug action.

    abstract::During the past decade remarkable progress in molecular genetics and the possibility of manipulating cells so that the expression of genes can directly 'report' on drug activity has produced major changes in drug development strategies. The recent description and pharmacological validation of reporter mice for in vivo...

    journal_title:Trends in pharmacological sciences

    pub_type: 杂志文章,评审


    authors: Maggi A,Ottobrini L,Biserni A,Lucignani G,Ciana P

    更新日期:2004-06-01 00:00:00

  • Phosphodiesterases reduce spontaneous sinoatrial beating but not the 'fight or flight' tachycardia elicited by agonists through Gs-protein-coupled receptors.

    abstract::Cyclic AMP (cAMP) steers the generation of basal heart beat in the sinoatrial node. It also induces sinoatrial tachycardia and increased cardiac force, elicited through activation of Gs-protein-coupled receptors (GsPCRs). Phosphodiesterases (PDEs) hydrolyse cAMP. In the heart mainly PDE3 and PDE4 would be expected to ...

    journal_title:Trends in pharmacological sciences

    pub_type: 杂志文章


    authors: Kaumann AJ

    更新日期:2011-07-01 00:00:00

  • Chemokines, chemokine receptors and small-molecule antagonists: recent developments.

    abstract::The physiological roles of chemokine receptors have expanded beyond host defense and now represent important targets for intervention in several disease indications. Chemokine receptors have joined the ranks of other members of the G-protein-coupled receptor (GPCR) family in therapeutic potential as small-molecule che...

    journal_title:Trends in pharmacological sciences

    pub_type: 杂志文章,评审


    authors: Onuffer JJ,Horuk R

    更新日期:2002-10-01 00:00:00

  • Thiol-Based Drugs in Pulmonary Medicine: Much More than Mucolytics.

    abstract::Thiol-based drugs are considered as mucolytics because they decrease the viscosity and mostly decrease the elasticity of bronchial secretions by reducing disulfide bonds in proteins. However, they can also act as antioxidant drugs directly through free sulfhydryl groups that serve as a source of reducing equivalents, ...

    journal_title:Trends in pharmacological sciences

    pub_type: 杂志文章


    authors: Cazzola M,Calzetta L,Page C,Rogliani P,Matera MG

    更新日期:2019-07-01 00:00:00

  • Receptors coupled to heterotrimeric G proteins of the G12 family.

    abstract::Much regarding the engagement of the G(12) family of heterotrimeric G proteins (G(12) and G(13)) by agonist-activated receptors remains unclear. For example, the identity of receptors that couple unequivocally to G(12) and G(13) and how signals are allocated among these and other G proteins remain open questions. Part...

    journal_title:Trends in pharmacological sciences

    pub_type: 杂志文章,评审


    authors: Riobo NA,Manning DR

    更新日期:2005-03-01 00:00:00

  • Kill 'Em All: Efgartigimod Immunotherapy for Autoimmune Diseases.

    abstract::Neonatal Fc receptors (FcRns) recycle IgGs by preventing their lysosome degradation. As this process also enhances half-life of pathogenic auto-IgG, inspired from the mechanisms of intravenous immunoglobulin, several inhibitors of IgG-FcRn interface have been conceived for treating autoimmune diseases. Among them, the...

    journal_title:Trends in pharmacological sciences

    pub_type: 杂志文章,评审


    authors: Bayry J,Kaveri SV

    更新日期:2018-11-01 00:00:00